Kefallinou Dionysia, Grigoriou Maria, Boumpas Dimitrios T, Tserepi Angeliki
Institute of Nanoscience and Nanotechnology, National Center for Scientific Research "Demokritos", Patr. Gregoriou Ε' and 27 Neapoleos Str., Aghia Paraskevi, 15341 Athens, Greece.
Laboratory of Inflammation and Autoimmunity, Biomedical Research Foundation, Academy of Athens, 11527 Athens, Greece.
Bioengineering (Basel). 2024 Jul 24;11(8):748. doi: 10.3390/bioengineering11080748.
Bone marrow has raised a great deal of scientific interest, since it is responsible for the vital process of hematopoiesis and is affiliated with many normal and pathological conditions of the human body. In recent years, organs-on-chips (OoCs) have emerged as the epitome of biomimetic systems, combining the advantages of microfluidic technology with cellular biology to surpass conventional 2D/3D cell culture techniques and animal testing. Bone-marrow-on-a-chip (BMoC) devices are usually focused only on the maintenance of the hematopoietic niche; otherwise, they incorporate at least three types of cells for on-chip generation. We, thereby, introduce a BMoC device that aspires to the purely in vitro generation and maintenance of the hematopoietic niche, using solely mesenchymal stem cells (MSCs) and hematopoietic stem and progenitor cells (HSPCs), and relying on the spontaneous formation of the niche without the inclusion of gels or scaffolds. The fabrication process of this poly(dimethylsiloxane) (PDMS)-based device, based on replica molding, is presented, and two membranes, a perforated, in-house-fabricated PDMS membrane and a commercial poly(ethylene terephthalate) (PET) one, were tested and their performances were compared. The device was submerged in a culture dish filled with medium for passive perfusion via diffusion in order to prevent on-chip bubble accumulation. The passively perfused BMoC device, having incorporated a commercial poly(ethylene terephthalate) (PET) membrane, allows for a sustainable MSC and HSPC co-culture and proliferation for three days, a promising indication for the future creation of a hematopoietic bone marrow organoid.
骨髓引发了大量的科学关注,因为它负责造血这一重要过程,且与人体的许多正常和病理状况相关。近年来,芯片器官(OoC)作为仿生系统的典范应运而生,它将微流控技术的优势与细胞生物学相结合,以超越传统的二维/三维细胞培养技术和动物实验。芯片骨髓(BMoC)装置通常仅专注于造血微环境的维持;否则,它们会纳入至少三种类型的细胞以在芯片上生成。因此,我们引入了一种BMoC装置,该装置旨在仅使用间充质干细胞(MSC)和造血干细胞及祖细胞(HSPC),依靠微环境的自发形成而不添加凝胶或支架,在体外纯生成和维持造血微环境。介绍了这种基于复制模塑的聚二甲基硅氧烷(PDMS)装置的制造过程,并测试了两种膜,一种是自制的多孔PDMS膜,另一种是商用聚对苯二甲酸乙二酯(PET)膜,并比较了它们的性能。该装置被浸没在装有培养基的培养皿中,通过扩散进行被动灌注,以防止芯片上出现气泡积聚。这种被动灌注的BMoC装置,结合了商用聚对苯二甲酸乙二酯(PET)膜,可实现间充质干细胞和造血干细胞及祖细胞的可持续共培养和增殖三天,这为未来创建造血骨髓类器官提供了一个有前景的迹象。